Skip to content

US · BHST

BioHarvest Sciences Inc. Common Stock

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Basic Materials · Agricultural Inputs
Headquarters
Vancouver, BC V6C 2T6

Price at previous close

$1.82

Market cap 39.16M

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for BioHarvest Sciences Inc. Common Stock (BHST) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About BioHarvest Sciences Inc. Common Stock

        BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.

        CEO
        Zaki Rakib
        Employees
        89
        Beta
        1.39

        Peer comparison

        Same-industry comparables, ranked by market cap.

        The peer comparison table is shown only to users with a Pro subscription.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.